MedPath

Iomeprol

Generic Name
Iomeprol
Drug Type
Small Molecule
Chemical Formula
C17H22I3N3O8
CAS Number
78649-41-9
Unique Ingredient Identifier
17E17JBP8L

Overview

Iomeprol has been investigated for the diagnostic of Coronary Artery Disease.

Background

Iomeprol has been investigated for the diagnostic of Coronary Artery Disease.

Indication

用于静脉尿路造影(成人包括肾脏损害或糖尿病患者)、CT(躯干)、常规血管造影、动脉、心血管造影(成人和儿童)、常规选择性冠状动脉造影、介入性冠状动脉造影、瘘管造影、乳管造影、泪囊造影和涎管造影。

Associated Conditions

No associated conditions information available.

FDA Approved Products

Iomeron
Manufacturer:BRACCO DIAGNOSTICS INC
Route:INTRAVASCULAR
Strength:714 mg in 1 mL
Approved: 2022/07/21
NDC:0270-7350
Iomeron
Manufacturer:BIPSO GmbH
Route:INTRAVASCULAR
Strength:612 mg in 1 mL
Approved: 2022/07/21
NDC:76381-730
Iomeron
Manufacturer:BIPSO GmbH
Route:INTRAVASCULAR
Strength:714 mg in 1 mL
Approved: 2022/07/21
NDC:76381-735
Iomeron
Manufacturer:BIPSO GmbH
Route:INTRAVASCULAR
Strength:612 mg in 1 mL
Approved: 2022/07/21
NDC:76381-930
Iomeron
Manufacturer:BIPSO GmbH
Route:INTRAVASCULAR
Strength:816 mg in 1 mL
Approved: 2022/07/21
NDC:76381-940

Singapore Approved Products

IOMERON 400 INJECTION 400 mg/ml
Manufacturer:PATHEON ITALIA S.P.A
Form:INJECTION
Strength:400 mg/ml
Online:Yes
Approved: 1995/11/24
Approval:SIN08458P
IOMERON 300 INJECTION 300 mg/ml
Manufacturer:Patheon Italia S.p.A
Form:INJECTION
Strength:300 mg/ml
Online:Yes
Approved: 1995/11/30
Approval:SIN08457P
IOMERON 350 INJECTION 350 mg/ml
Manufacturer:Patheon Italia S.p.A
Form:INJECTION
Strength:350 mg/ml
Online:Yes
Approved: 1995/11/30
Approval:SIN08462P

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath